Needham downgrades Biogen to Hold on lack of share catalysts
Needham downgraded Biogen (BIIB) to Hold from Buy without a price target The firm does not see a meaningful source of upside for the shares ...
News Medical on MSN2h
Stilla Technologies with Source BioScience brings advanced genomics solutions to the UK market
Stilla Technologies, a global leader in digital PCR (dPCR) solutions, has announced a strategic partnership with Source ...
uk.investing.com on MSN20h
Needham downgrades Biogen on slow growth of Alzheimer's drug
Investing.com - Needham downgraded Biogen Inc (NASDAQ:BIIB) on Monday, citing slower-than-expected growth for its Alzheimer's ...
Reuters22h
United Kingdom
United Kingdomcategory Masked men break into UK's Windsor Castle estate, The Sun reports 8:47 AM UTC United Kingdomcategory UK retail industry plays down threat to food supplies from possible ...